{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:35:07Z","timestamp":1765884907343,"version":"3.48.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,16]]},"DOI":"10.7759\/cureus.99362","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:30:49Z","timestamp":1765884649000},"source":"Crossref","is-referenced-by-count":0,"title":["Post-COVID-19 Inflammatory Myopathy With Dermatomyositis\u2013Mixed Connective Tissue Disease (MCTD) Overlap Features and Epiglottitis: A Case Report"],"prefix":"10.7759","author":[{"given":"Nicholas","family":"Lorenz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amia","family":"Mourad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"Weiderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Daniel","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-025-09458-x","article-title":"Ulcerative supraglottitis - a unique presentation of COVID-19 infection","volume":"282","author":"Wechsler S","year":"2025","unstructured":"Wechsler S, Pitaro J, Shlamkovich N, Kalmovich LM, Gavriel H. Ulcerative supraglottitis - a unique presentation of COVID-19 infection. Eur Arch Otorhinolaryngol. 2025, 282:3747-56. 10.1007\/s00405-025-09458-x","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18781-2","article-title":"Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium","volume":"11","author":"Sajuthi SP","year":"2020","unstructured":"Sajuthi SP, DeFord P, Li Y, et al.. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium. Nat Commun. 2020, 11:5139. 10.1038\/s41467-020-18781-2","journal-title":"Nat Commun"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O'Callaghan A","year":"2018","unstructured":"Selva-O'Callaghan A, Pinal-Fernandez I, Trallero-Aragu\u00e1s E, Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. Lancet Neurol. 2018, 17:816-28. 10.1016\/S1474-4422(18)30254-0","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2017.06.066","article-title":"Facts and controversies in mixed connective tissue disease. (Article in Spanish)","volume":"150","author":"Mart\u00ednez-Barrio J","year":"2018","unstructured":"Mart\u00ednez-Barrio J, Valor L, L\u00f3pez-Longo FJ. Facts and controversies in mixed connective tissue disease. (Article in Spanish). Med Clin (Barc). 2018, 150:26-32. 10.1016\/j.medcli.2017.06.066","journal-title":"Med Clin (Barc)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103070","article-title":"Molecular mimicry and autoimmunity in the time of COVID-19","volume":"139","author":"Rojas M","year":"2023","unstructured":"Rojas M, Herr\u00e1n M, Ram\u00edrez-Santana C, Leung PS, Anaya JM, Ridgway WM, Gershwin ME. Molecular mimicry and autoimmunity in the time of COVID-19. J Autoimmun. 2023, 139:103070. 10.1016\/j.jaut.2023.103070","journal-title":"J Autoimmun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg SA","year":"2005","unstructured":"Greenberg SA, Pinkus JL, Pinkus GS, et al.. Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol. 2005, 57:664-78. 10.1002\/ana.20464","journal-title":"Ann Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.2004","article-title":"Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died","volume":"78","author":"Aschman T","year":"2021","unstructured":"Aschman T, Schneider J, Greuel S, et al.. Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died. JAMA Neurol. 2021, 78:948-60. 10.1001\/jamaneurol.2021.2004","journal-title":"JAMA Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1977","article-title":"Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies","volume":"305","author":"Rider LG","year":"2011","unstructured":"Rider LG, Miller FW. Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. JAMA. 2011, 305:183-90. 10.1001\/jama.2010.1977","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-015-8510-y","article-title":"A comprehensive overview on myositis-specific antibodies: New and old biomarkers in idiopathic inflammatory myopathy","volume":"52","author":"Satoh M","year":"2017","unstructured":"Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EK. A comprehensive overview on myositis-specific antibodies: New and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol. 2017, 52:1-19. 10.1007\/s12016-015-8510-y","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/08916930400022681","article-title":"Anti-Mi-2 antibodies","volume":"38","author":"Ghirardello A","year":"2005","unstructured":"Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Bendo R, Gambari PF, Doria A. Anti-Mi-2 antibodies. Autoimmunity. 2005, 38:79-83. 10.1080\/08916930400022681","journal-title":"Autoimmunity"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2014.01.008","article-title":"The diagnosis and classification of mixed connective tissue disease","volume":"48-49","author":"Tani C","year":"2014","unstructured":"Tani C, Carli L, Vagnani S, Talarico R, Baldini C, Mosca M, Bombardieri S. The diagnosis and classification of mixed connective tissue disease. J Autoimmun. 2014, 48-49:46-9. 10.1016\/j.jaut.2014.01.008","journal-title":"J Autoimmun"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.0673","article-title":"Association of dermatomyositis sine dermatitis with anti-nuclear matrix protein 2 autoantibodies","volume":"77","author":"Inoue M","year":"2020","unstructured":"Inoue M, Tanboon J, Hirakawa S, et al.. Association of dermatomyositis sine dermatitis with anti-nuclear matrix protein 2 autoantibodies. JAMA Neurol. 2020, 77:872-7. 10.1001\/jamaneurol.2020.0673","journal-title":"JAMA Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2016.03.002","article-title":"Mixed connective tissue disease","volume":"30","author":"Gunnarsson R","year":"2016","unstructured":"Gunnarsson R, Hetlevik SO, Lilleby V, Molberg \u00d8. Mixed connective tissue disease. Best Pract Res Clin Rheumatol. 2016, 30:95-111. 10.1016\/j.berh.2016.03.002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13050983","article-title":"Multisystem inflammatory syndrome in adults associated with recent infection with COVID-19","volume":"13","author":"Zahornacky O","year":"2023","unstructured":"Zahornacky O, Porub\u010din \u0160, Rovnakova A, Jarcuska P. Multisystem inflammatory syndrome in adults associated with recent infection with COVID-19. Diagnostics (Basel). 2023, 13:983. 10.3390\/diagnostics13050983","journal-title":"Diagnostics (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008443","article-title":"More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies","volume":"93","author":"Pinal-Fernandez I","year":"2019","unstructured":"Pinal-Fernandez I, Mecoli CA, Casal-Dominguez M, et al.. More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies. Neurology. 2019, 93:e1768-77. 10.1212\/WNL.0000000000008443","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007188","article-title":"Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies","volume":"92","author":"Casal-Dominguez M","year":"2019","unstructured":"Casal-Dominguez M, Pinal-Fernandez I, Corse AM, et al.. Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies. Neurology. 2019, 92:e1416-26. 10.1212\/WNL.0000000000007188","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/443482-post-covid-19-inflammatory-myopathy-with-dermatomyositis-mixed-connective-tissue-disease-mctd-overlap-features-and-epiglottitis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:30:49Z","timestamp":1765884649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/443482-post-covid-19-inflammatory-myopathy-with-dermatomyositis-mixed-connective-tissue-disease-mctd-overlap-features-and-epiglottitis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.99362","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,16]]}}}